High‐risk human papillomavirus (hrHPV) DNA tests have excellent sensitivity for detection of
cervical intraepithelial neoplasia 2 or higher (CIN2+). A drawback of hrHPV screening …

BACKGROUND: Persistent infection% by with high risk human papillomavirus (hrHPV) types
causes cervical cancer but most women who test positive are at very low risk of neoplasia …

Aim High-risk human papillomavirus (hrHPV)-based screening is becoming increasingly
important, either by supplementing or replacing the traditional cytology-based cervical Pap …

Abstract In 2015, the American Society for Colposcopy and Cervical Pathology and the
Society of Gynecologic Oncology issued interim guidance for the use of a human …

Background Vigilant management of women with high-risk human papillomavirus (hrHPV) is
necessary in cancer screening programs. To this end, we evaluated the performance of S5 …

Objective triage strategies are required to prevent unnecessary referrals for colposcopy in
population‐based screening programs using primary high‐risk human papillomavirus …

Methylation of host and viral genes is promising for triage of women with high‐risk human
papillomavirus infections (hrHPV). Using a population‐based sample of hrHPV positive …

Triaging of women positive for high‐risk human papillomavirus (hrHPV) on self‐collected
samples requires a molecular reflex test to avoid recall for cytology or visual tests. We …

Human papillomavirus (HPV)‐based cervical cancer screening requires triage of HPV
positive women to identify those at risk of cervical intraepithelial neoplasia grade 2 (CIN2) or …

Testing for high‐risk (hr) types of human papillomavirus (HPV) is highly sensitive as a
screening test of high‐grade cervical intraepithelial neoplastic (CIN2/3) disease, the …